Emily, God Bless You and your Mom. You are in my thoughts and prayers. I'm in Charlotte and Dr. Brennan, in Charlotte, is the one who FINALLY diagonsed my aunt's cancer after screwing around with doctors in Gastonia for 3 months. Her surgeon is Dr. Kamerer with Charlotte Eye Ear Nose and Throat. He is also over the oral cancer department at Carolinas Medical Center. Not sure where you are or where surgery was done.

Here are 2 brief articles I found on Kamerer and Brennan:

Kamerer Donald's Biography
Donald B. Kamerer, Jr., MD Additional Information:CHARLOTTE EYE EAR NOSE & THROAT ASSOCIATES EDUCATION:Undergraduate: Summa cum laude, Yale University, 1978 Medical School: Harvard Medical School, 1982.Internship: General surgery, Boston University Affiliated Surgical Program, 1983.Residency: Otolaryngology - Head and Neck Surgery, University of Pittsburgh, a program consistently mentioned as one of the finest in the nation, 1987.BOARD CERTIFICATION: American Board of Otolaryngology. He is a fellow of the American Academy of Otolaryngology - Head and Neck Surgery.MEMBERSHIPS: North Carolina Medical Society and the Mecklenburg Medical Society.MEDICAL STAFF: Presbyterian Hospital and Carolinas Medical Center. Dr. Kamerer currently serves as Chief of the Department of Otolaryngology - Head and Neck Surgery at Carolinas Medical Center and is the Surgical Director of the Multidisciplinary Clinic for Head and Neck Cancer at Carolinas Medical Center's Blumenthal Cancer Center, where he participates in research related to the multidisciplinary approach to head and neck cancer. He sometimes serves as a surgical representative for Presbyterian Hospital's Multidisciplinary Head and Neck Clinic.EXPERTISE: Evaluation and treatment of head and neck tumors, diseases of the salivary glands, thyroid and parathyroid disorders, skullbase surgery, transseptal surgery for pituitary tumors, voice disorders, and endoscopic sinus surgery.

Mike Brennan DDS, MHS

Research Interests: Pathophysiology and Management of Sj�gren�s Syndrome and Other Salivary Gland Diseases, Oral Mucositis and Other Oral Complications from Cancer Therapies, Dental Management Issues of Medically Complex Patients

Dr. Brennan received a Certificate in Oral Medicine at the National Institutes of Health (NIH) in Bethesda, Md., and a Masters of Health Science in Clinical Research from Duke University. Upon completion of his master's, Dr. Brennan joined the Department of Oral Medicine at Carolinas Medical Center in June 2000. He is currently the department�s Associate Chairman, Oral Medicine Residency Director, and Director of the Sj�gren�s Syndrome and Salivary Disorders Center. To date, he has written more than 50 peer-reviewed articles and book chapters.

In the field of Sj�gren�s syndrome, there are four ongoing and recent studies, two of which are NIH funded. The two NIH studies evaluate the genetics and proteomics of primary Sj�gren�s syndrome while the third is a randomized-controlled trial, (RCT) to evaluate the role of hypnosis in patients diagnosed with primary and secondary Sj�gren�s syndrome. The final study is a recent multi-center RCT, which evaluates a new topical agent for Sj�gren�s syndrome and was completed at Carolinas Medical Center with promising results.

Dr. Brennan is additionally the principal investigator at Carolinas Medical Center for a multi-center study to evaluate the impact of oral mucositis in a wide range of cancer therapies. He also holds the following positions:

Co-Chairman of the Oral Care Study Group which is part of Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)
Project Organizer of the project �Oral Care Study Group Systematic Review� with over 70 international participants. The primary goals of this project include an identification of the prevalence/incidence of oral complications (i.e. xerostomia, dysphagia, pain, osteoradionecrosis, bisphosphonate-associated osteonecrosis, dysgeusia, fungal, viral and dental/periodontal disease). Quality of life, economic impact and management recommendations are also key components of this project.
Along with research initiatives evaluating the patient impact of oral complications, Dr. Brennan has both recognized and ongoing research evaluating the mechanisms associated with oral mucositis. He has already evaluated gene expression changes in epithelial tissue associated with chemotherapy in leukemic patients. Results from this study and an additional ongoing study evaluating gene expression changes in archival tissue samples from patients treated with chemotherapy at various time points in time, will help clarify the pathophysiology of mucositis and identify potential future therapeutic options for oncology patients in the dose-limiting complication of mucositis.

Recent Publications

Brennan MT, Runyon MS, Batts JJ, Fox PC, Kent ML, Cox TL, H. Norton HJ, Lockhart PB. Odontogenic signs and symptoms as predictors of odontogenic infection: A clinical trial. J Am Dent Assoc 2006; 137: 62-66. [PMID: 16457000]

Brennan MT, von Bultzingslowen I, Schubert MM, Keefe D. Alimentary mucositis: putting the guidelines into practice. Support Care Cancer 2006; 14: 573-579. [PMID: 16622650]

Brennan MT, Wynn RL, Miller CS. Aspirin and bleeding in dentistry: an update and recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104: 316-323 [PMID: 17618144]

Brennan MT, Kent ML, Fox PC, Norton HJ, Lockhart PB. The impact of oral disease and nonsurgical treatment on bacteremia in children. J Am Dent Assoc 2007; 138: 80-85. [PMID: 17197406]

Brennan MT, Woo SB, Lockhart PB. Dental treatment planning and management in the